| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.046 | 48.021 | 44.872 | 42.458 | 58.049 | 14.188 | 56.556 | 60.547 | 37.798 | 32.800 |
| Total Income - EUR | 49.073 | 48.129 | 45.205 | 44.499 | 60.403 | 14.838 | 58.054 | 61.086 | 38.952 | 34.759 |
| Total Expenses - EUR | 15.905 | 15.138 | 13.531 | 17.279 | 20.480 | 14.680 | 14.113 | 15.610 | 17.551 | 19.624 |
| Gross Profit/Loss - EUR | 33.168 | 32.991 | 31.675 | 27.220 | 39.923 | 158 | 43.940 | 45.476 | 21.402 | 15.135 |
| Net Profit/Loss - EUR | 31.696 | 32.366 | 30.029 | 26.779 | 39.328 | 35 | 43.503 | 44.884 | 18.293 | 12.448 |
| Employees | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Gyn-Adrialin-Autoact Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.497 | 14.474 | 13.784 | 13.094 | 12.411 | 11.756 | 11.084 | 10.706 | 10.262 | 8.381 |
| Current Assets | 60.051 | 89.853 | 110.212 | 110.706 | 138.317 | 163.610 | 170.795 | 213.751 | 202.130 | 192.218 |
| Inventories | 1.114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10 | 1.820 | 2.053 | 10.098 | 10.653 | 30.567 | 3.529 | 13.173 | 8.591 | 38.683 |
| Cash | 58.928 | 88.033 | 108.159 | 100.609 | 127.664 | 133.043 | 167.266 | 200.578 | 193.539 | 153.534 |
| Shareholders Funds | 63.177 | 94.898 | 112.376 | 102.710 | 127.405 | 125.024 | 159.892 | 198.869 | 179.873 | 142.237 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.521 | 9.565 | 11.747 | 21.090 | 23.323 | 50.548 | 21.987 | 25.588 | 32.519 | 58.361 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8219 - 8219" | |||||||||
| CAEN Financial Year |
8219
|
|||||||||
Comments - Gyn-Adrialin-Autoact Srl